Delivery Order SPE2DB22D1106-SPE2DB25FFAC8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Dasatinib 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $37,364.76, with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,193.03 to AmerisourceBergen Drug Corp for Dasatinib 50 mg tablets (60-count supply) on August 11, 2025, with a completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- This delivery order, awarded on July 24, 2025, represents a $43,339.66 firm fixed-price contract for 60-count bottles of Dasatinib 50 mg tablets to be delivered to Conshohocken, Pennsylvania. The Defense Logistics Agency awarded this non-competitive delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement. The award is expected to be completed by July 25, 2025, reflecting a rapid fulfillment timeline typical of...
- The Defense Logistics Agency awarded a delivery order valued at $8,260.56 to AmerisourceBergen Drug Corp for the supply of Dasatinib 100 mg tablets (30-count units) with a firm fixed price structure. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively made with no set-aside designation, and delivery is...
- The Defense Logistics Agency awarded a $30,587.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Dasatinib 50 mg tablets, with an ultimate completion date of July 29, 2025. This non-set-aside contract was competitively awarded on July 28, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dasatinib 140 mg tablets, a medication used to treat certain types of cancer. The contract has a ceiling value of $11,239.87 and a period of performance ending on July 3, 2025. The contract is a firm fixed-price delivery order, meaning the price will not change regardless of the...
- This federal contract award, valued at $5,456.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568096600 - Dasatinib 20 mg Tablet 60s, a prescription medication, with a completion date of May 2, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This is a $29,367.09 firm-fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of DASATINIB 100 MG TABLET 30S medication. The contract has an ultimate completion date of July 7, 2025 and is not set aside. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DASATINIB 80 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price of $12,790.96 and a period of performance ending on July 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $13,876 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100mg dasatinib tablets. Under the contract, Amerisourcebergen will deliver 30 bottles of the oncology drug to a facility in Conshohocken, Pennsylvania by August 24, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and medical supplies to support military...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFAC8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Dasatinib 80 mg tablets (30-count packaging) under a firm fixed-price contract valued at $82,393.53. The order is set to be completed by July 29, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was competitively awarded this non-set-aside contract to supply Dasatinib, an oncology medication, to support military and federal healthcare systems. The company maintains an extensive portfolio of federal pharmaceutical contracts with the DLA and Defense Health Agency, regularly fulfilling delivery orders for brand-name and generic medications across multiple therapeutic categories. This transaction exemplifies AmerisourceBergen's role as a prime vendor in the DLA's global pharmaceutical support program, enabling flexible medical supply delivery to defense and civilian healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.4k | 7/28/25 |